Clinical factors associated with outcome in metastatic renal cell carcinoma patients treated with VEGF-targeted therapy

被引：0
|
作者：
Golshayan, A. [1 ]
Choueiri, T. K. [1 ]
Elson, P. [1 ]
Garcia, J. A. [1 ]
Khaswneh, M. [1 ]
Usman, S. [1 ]
Tamaskar, I. [1 ]
Wood, L. [1 ]
Rini, B. I. [1 ]
Bukowski, R. M. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cessation of VEGF-targeted therapy in patients with metastatic renal cell carcinoma (mRCC): Feasibility and clinical outcome
    Sadeghi, S.
    Albiges, L.
    Wood, L. S.
    Black, S. L.
    Gilligan, T. D.
    Dreicer, R.
    Garcia, J. A.
    Escudier, B. J.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [2] The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
    Al-Marrawi, Mhd Y.
    Rini, Brian I.
    Harshman, Lauren C.
    Bjarnason, Georg
    Wood, Lori
    Vaishampayan, Ulka
    MacKenzie, Mary
    Knox, Jennifer J.
    Agarwal, Neeraj
    Al-Harbi, Hulayel
    Kollmannsberger, Christian
    Tan, Min-Han
    Rha, Sun Young
    Donskov, Frede N.
    North, Scott
    Choueiri, Toni K.
    Heng, Daniel Y.
    TARGETED ONCOLOGY, 2013, 8 (03) : 203 - 209
  • [3] The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
    Mhd Y. Al-Marrawi
    Brian I. Rini
    Lauren C. Harshman
    Georg Bjarnason
    Lori Wood
    Ulka Vaishampayan
    Mary MacKenzie
    Jennifer J. Knox
    Neeraj Agarwal
    Hulayel Al-Harbi
    Christian Kollmannsberger
    Min-Han Tan
    Sun Young Rha
    Frede N. Donskov
    Scott North
    Toni K. Choueiri
    Daniel Y. Heng
    Targeted Oncology, 2013, 8 : 203 - 209
  • [4] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    LABORATORY INVESTIGATION, 2013, 93 : 239A - 239A
  • [5] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    MODERN PATHOLOGY, 2013, 26 : 239A - 239A
  • [6] The association of clinical outcome to front-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC) patients (Pts)
    Al-Marrawi, M. Y.
    Rini, B. I.
    Harshman, L. C.
    Bjarnason, G. A.
    Wood, L.
    Vaishampayan, U. N.
    MacKenzie, M. J.
    Knox, J. J.
    Agarwal, N.
    Kollmannsberger, C. K.
    Tan, M.
    Rha, S. Y.
    Donskov, F.
    North, S. A.
    Choueiri, T. K.
    Heng, D. Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Clinical outcomes according to ethnicity in patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT).
    Bosse, Dominick
    Xie, Wanling
    Wells, Connor
    Lalani, Aly-Khan A.
    Donskov, Frede
    Bent, Alisha
    Sim, Hao-Wen
    Beuselinck, Benoit
    Bamias, Aristotelis
    Porta, Camillo
    Vaishampayan, Ulka N.
    Pal, Sumanta K.
    Agarwal, Neeraj
    Srinivas, Sandy
    Rini, Brian I.
    Alva, Ajjai Shivaram
    Wood, Lori
    Kapoor, Anil
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Metastatic renal cell carcinoma (mRCC) patients (pts) with sarcomatoid features treated with VEGF-targeted therapy
    Golshayan, A. R.
    George, S.
    Heng, D. Y.
    Elson, P.
    Wood, L.
    Garcia, J. A.
    Aydin, H.
    Zhou, M.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents
    Vano, Yann-Alexandre
    Tartour, Eric
    Fournier, Laure S.
    Beuselinck, Benoit
    Mejean, Arnaud
    Oudard, Stephane
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 523 - 542
  • [10] Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials
    Sorich, Michael J.
    Kichenadasse, Ganessan
    Rowland, Andrew
    Woodman, Richard J.
    Mangoni, Arduino A.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (09) : 2293 - 2299
12345